Joshua McGee
CSO & Co-Founder Keylicon Biosciences
Seminars
Tuesday 21st July 2026
Overcoming the Innate Immune Response of Self-Amplifying RNAs to Unlock Improved Vaccines & Therapeutics
3:45 pm
- The innate response to self-amplifying RNAs can by overcome by incorporating the right modified nucleotides
- Engineered saRNA vectors substantially increase protein expression, improving replication, stability, and translation
- Advanced vector designs unlock differentiated performance, enabling potent multivalent vaccines and tissue-specific therapeutic expression
